Skip to main content

Table 1 Socioeconomic and clinical characteristics of new users of simvastatin (n = 108,806) and atorvastatin (n = 7,464)

From: Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study

  Simvastatin Atorvastatin
Variable n % n %
Gender     
 Female 51,130 47.0 3,389 45.4
 Male 57,676 53.0 4,075 54.6
Age (years)     
 18–39 2,482 2.3 284 3.8
 40–49 9,696 8.9 779 10.4
 50–59 25,398 23.3 1,963 26.3
 60–69 37,303 34.3 2,549 34.2
 70–79 25,224 23.2 1,531 20.5
 80– 8,703 8.00 358 4.8
Background     
 Swedish 90,517 83.2 5,844 78.3
 Migrant 18,289 16.8 1,620 21.7
Place of birth if foreign background     
 Sweden 756 4.1 85 5.2
 Other Nordic country 6,495 35.5 452 27.9
 Other EU27 country 3,567 19.5 373 23.0
 Other European country 2,886 15.8 229 14.1
 Africa 482 2.6 43 2.7
 North America 186 1.0 28 1.7
 South America 473 2.6 55 3.4
 Asia and Oceania 2,872 15.7 296 18.3
 Former Soviet Union 115 0.6 14 0.9
 Unknown place of birth 457 2.5 45 2.8
Level of education     
 Primary school, <9 years 19,199 17.7 1100 14.7
 Primary school, 9 years 9,180 8.4 707 9.5
 Secondary school 40,097 36.9 2862 38.3
 University, <2 years 2,962 2.7 234 3.1
 University, ≥2 years 16,621 15.3 1405 18.8
 Postgraduate 714 0.7 87 1.2
 Unknown education level 20,033 18.4 1069 14.3
Previous disease     
 Cardiovascular disease 25,266 23.2 1,278 17.1
 Renal disease 388 0.4 93 1.2
 Both 492 0.5 40 0.5
Pharmacological diabetes treatment     
 Oral antidiabetics 9,798 9.0 581 7.8
 Insulin 4,553 4.2 400 5.4
 Combination of these 3,056 2.8 229 3.1
 Total 17,407 16.0 1,210 16.2